Press release: Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe
New campus expected to deliver up to £900m of new investment, an estimated 1.4 million square feet of laboratory and office facilities, providing up to 5,000 new jobs in Stevenage.
London, 8th February 2023: The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, today announces its involvement in the development of a major new campus for life science businesses in Stevenage, Hertfordshire. Today’s announcement from the CGT Catapult follows the announcement by UBS Asset Management’s Real Estate & Private Markets and Reef Group in July 2022 that they intend to invest £900m in a joint venture to develop a new life sciences campus in Stevenage.
Read the entire news report here. Published on the 7th of February 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (17 mai 2023). Press release: Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe . ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/o6b7





